SNT 3.45% 3.0¢ syntara limited

bronchiotol approved, page-3

  1. 51 Posts.

    Well after coming in on the I.P.O.and rideing the hi's and lows it was with great releif to read the news this morning.It has been 8 years to reach this point and as a patient punter I shall really be looking forward to the next 2/3 years.If the dots line up I may well be able to sell at my wishful target price,somewhere between $10/$20.
    As others have said there is more work to do,but as we have all experienced it is no mean feat to get a new drug to market and this now a launching pad(I hope)to a very bright future for the company and shareholders.Thanks to those posters who contribute regularly with a special mention for Lombard who I think does a sterling job.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.